RecruitingNCT07329257
Investigating Phenotypic, Epigenetic, and NeuroGenetic Traits in Rare and Ultra-rare Neurodevelopmental Disorders (Project PENGUIN)
Studying Infantile hypotonia-oculomotor anomalies-hyperkinetic movements-developmental delay syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Missouri-Columbia
- Principal Investigator
- W. David Arnold, MDUniversity of Missouri-Columbia
- Intervention
- No Intervention: Observational Cohort(other)
- Enrollment
- 100 enrolled
- Eligibility
- 99 years · All sexes
- Timeline
- 2025 – 2028
Study locations (1)
- University of Missouri - Columbia, Columbia, Missouri, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07329257 on ClinicalTrials.gov